Trilaciclib Dihydrochloride | m-entrepreneurship.com

Product Name :
Trilaciclib Dihydrochloride

Search keywords :
G-1

drugId :
null

Target Vo:
Cyclin-dependent kinase 6

Target Vo Short Name :
CDK6

Moa_Name:
Cyclin-dependent kinase 6 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2021

Origin Company_Name :
G1 Therapeutics Inc

Active Company_Name :
C.H. Boehringer Sohn Ag & Co. Kg

Active Indication_Name:
Chemotherapy-induced myelosuppression

In Active Indication_Name:
Colorectal Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HDAC3 Rabbit mAb In stock
Phospho-c-Jun (Ser243) Rabbit pAb custom synthesis
HSF1 Antibody (YA896): HSF1 Antibody (YA896) is an unconjugated, approximately 57-80 kDa, rabbit-derived, anti-HSF1 (YA896) monoclonal antibody. HSF1 Antibody (YA896) can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts